You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

PET Imaging and Beyond

  • Authors: Bonnie N. Joe, MD, PhD; Gary A. Ulaner, MD, PhD, FACNM; Katja Pinker-Domenig, MD, PhD, EBBI, FISMRM; Maxine S. Jochelson, MD; Linda Moy, MD; Elizabeth A. Morris, MD
  • CME / ABIM MOC / CE Released: 12/8/2022
  • Valid for credit through: 12/8/2023
Start Activity

  • Credits Available

    Physicians - maximum of 2.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 2.50 ABIM MOC points

    Nurses - 2.50 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Radiologic Technologists – maximum of 2.5 hours of ARRT Category A continuing education credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for radiologists, radiologic technologists, hematologists/oncologists, pathologists.

The goal of this activity is for the learner to be better able to effectively guide breast cancer treatment through the use of current and emerging imaging technology.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Efficacy of positron emission tomography (PET) images for treatment planning
    • Clinical data evaluating estrogen receptor (ER)-targeting and PET tracers in invasive lobular carcinoma (ILC)
    • Diagnostic potential of artificial intelligence (AI)
  • Demonstrate greater confidence in their ability to
    • Effectively guide breast cancer treatment through the use of current and emerging imaging technologies


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • Bonnie N. Joe, MD, PhD

    Professor in Residence
    Chief of Breast Imaging
    Department of Radiology and Biomedical Imaging
    University of California, San Francisco
    San Francisco, California

    Disclosures

    Bonnie N. Joe, MD, PhD, has the following relevant financial relationships:
    Research funding from: Kheiron Medical Technologies

  • Gary A. Ulaner, MD, PhD, FACNM

    Director of Molecular Imaging and Therapy
    Hoag Family Cancer Institute
    Professor of Radiology and Translational Genomics
    University of Southern California
    Newport Beach, California

    Disclosures

    Gary A. Ulaner, MD, PhD, FACNM, has the following relevant financial relationships:
    Consultant or advisor for: GE Healthcare; ImaginAb; Lantheus; Nuclidium
    Speaker or member of speakers bureau for: GE Healthcare; Lantheus
    Research funding from: GE Healthcare; ImaginAb; Lantheus

  • Katja Pinker-Domenig, MD, PhD, EBBI, FISMRM

    Director of Research
    Director of Breast MRI
    Breast Imaging Service
    Department of Radiology
    Memorial Sloan Kettering Cancer Center
    New York, New York

    Disclosures

    Katja Pinker-Domenig, MD, PhD, EBBI, FISMRM, has the following relevant financial relationships:
    Consultant or advisor for: AURA Health Technologies GmbH; Genentech, Inc.; Merantix Healthcare
    Speaker or member of speakers bureau for: IDKD 2019 (former); Olea Medical (former); Siemens Healthineers (former)

  • Maxine S. Jochelson, MD

    Chief, Breast Imaging Service
    Memorial Sloan Kettering Cancer Center
    New York, New York

    Disclosures

    Maxine S. Jochelson, MD, has the following relevant financial relationships:
    Speaker or member of speakers bureau for: General Electric
    Research funding from: General Electric (former)

  • Linda Moy, MD

    Professor
    Director of Breast MRI
    Department of Radiology
    NYU Grossman School of Medicine
    New York, New York

    Disclosures

    Linda Moy, MD, has the following relevant financial relationships:
    Consultant or advisor for: Guerbet; iCAD
    Research funding from: Google; Siemens

  • Elizabeth A. Morris, MD

    Professor
    Chair, Department of Radiology
    University of California
    Davis School of Medicine
    Sacramento, California

    Disclosures

    Elizabeth A. Morris, MD, has no relevant financial relationships.

Editor

  • Victoria Phoenix, BS

    Medical Education Director, Medscape, LLC

    Disclosures

    Victoria Phoenix, BS, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 2.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.

    Contact This Provider

  • American Registry of Radiologic Technologists (ARRT)

    This activity has been submitted to the American Society of Radiologic Technologists (ASRT) for 2.50 hours of ARRT Category A continuing education credit.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

PET Imaging and Beyond

Authors: Bonnie N. Joe, MD, PhD; Gary A. Ulaner, MD, PhD, FACNM; Katja Pinker-Domenig, MD, PhD, EBBI, FISMRM; Maxine S. Jochelson, MD; Linda Moy, MD; Elizabeth A. Morris, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 12/8/2022

Valid for credit through: 12/8/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

PET Imaging in Metastatic Breast Cancer

Did you know that PET/CT is not the best test for loco-regional staging in early disease?
Maxine S. Jochelson, MD, FSBI

Novel Strategies for Breast Cancer Assessment and Response

Did you know that MRI is currently the best imaging study for evaluating response to neoadjuvant chemotherapy in locally advanced breast cancer?
Bonnie N. Joe, MD, PhD

FES and FDG PET in ILC and IDC: Where Is the Clinical Impact?

Are you using FES PET/CT for determining which patients will not respond to endocrine therapy?
Gary A. Ulaner, MD, PhD, FACNM

How Artificial Intelligence Is Changing Breast Imaging

How can we improve our breast cancer detection rate without requiring additional reading time?
Linda Moy, MD

Precision Medicine and Radiogenomics: New Approaches for Diagnosis and Treatment of Breast Cancer

Precision medicine is "a bold concept, an audacious aspiration". Where are we now?
Katja Pinker-Domenig, MD, PhD, EBBI, FISMRM
 

Educational Impact Challenge

The goal of this activity is for the learners to be better able to effectively guide breast cancer treatment through the use of current and emerging imaging technology.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print